期刊
CLINICAL CANCER RESEARCH
卷 25, 期 9, 页码 2682-2684出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-19-0286
关键词
-
类别
资金
- Center for Cancer Research, the intramural program of the National Cancer Institute
- NATIONAL CANCER INSTITUTE [ZIABC010984] Funding Source: NIH RePORTER
The concept of treatment-refractory disease has evolved as checkpoint modulation has changed the therapeutic landscape for patients with metastatic melanoma. Developing meaningful salvage strategies will involve the exploration of combination therapies and new immunotherapeutics, including adoptive transfer of tumor-infiltrating lymphocytes or other T-cell-based therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据